Stearoyl-CoA desaturase: A novel control point of lipid metabolism and insulin sensitivity

European Journal of Lipid Science and Technology

Volumn 110, Issue 2, 2008, Pages 93-100

  Dobrzyn, Pawel ^a   Ntambi, James M ^b   Dobrzyn, Agnieszka ^a  

^a NENCKI INSTITUTE OF EXPERIMENTAL BIOLOGY   (Poland)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Insulin signaling; Lipids; Metabolism

Indexed keywords

MUS;

EID: 42949155123     PISSN: 14387697     EISSN: 14389312     Source Type: Journal    
DOI: 10.1002/ejlt.200700249     Document Type: Review

References (62)

1. L. H. Storlien, A. B. Jenkins, D. J. Chisholm, W. S. Pascoe, S. Khouri, E. W. Kraegen: Influence of dietary fat composition on development of insulin resistance in rats. Relationship to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes. 1991, 40, 280-289.
2. D. A. Pan, A. J. Hulbert, L. H. Storlein: Dietary fats, membrane phospholipids and obesity. J Nutr. 1994, 124, 1555-1565.
3. B. H. Jones, M. A. Maher, W. J. Banz, M. B. Zemel, J. Whelan, P. J. Smith, N. Moustaid: Adipose tissue stearoyl-CoA desaturase mRNA is increased by obesity and decreased by polyunsaturated fatty acids. Am J Physiol. 1996, 271, E44-E49.
4. R. Solans, C. Motta, R. Sola, A. E. La Ville, J. Lima, P. Simeon, N. Montella, L. Armadans-Gil, V. Fonollosa, M. Vilardell: Abnormalities of erythrocyte membrane fluidity, lipid composition, and lipid peroxidation in systemic sclerosis: Evidence of free radical-mediated injury. Arthritis Rheum. 2000, 43, 894-900.
5. G. Agatha, R. Hafer, F. Zintl: Fatty acid composition of lymphocyte membrane phospholipids in children with acute leukemia. Cancer Lett. 2001, 173, 139-144.
6. J. W. Pettegrew, K. Panchalingam, R. L. Hamilton, R. J. McClur: Brain membrane phospholipid alterations in Alzheimer's disease. Neurochem Res. 2001, 26, 771-782.
7. A. Dobrzyn, J. M. Ntambi: The role of stearoyl-CoA desaturase in body weight regulation. Trends Cardiovasc Med. 2004, 14, 77-81.
8. A. Dobrzyn, J. M. Ntambi: The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins Leukot Essent Fatty Acids. 2005, 73, 35-41.
9. S. M. Rahman, A. Dobrzyn, P. Dobrzyn, S. H. Lee, M. Miyazaki, J. M. Ntambi: Stearoyl-CoA desaturase 1 deficiency elevates insulin-signaling components and down-regulates protein-tyrosine phosphatase 1B in muscle. Proc Natl Acad Sci USA. 2003, 100, 11110-11115.
10. P. Dobrzyn, A. Dobrzyn: Stearoyl-CoA desaturase: A new therapeutic target of liver steatosis. Drug Dev Res. 2006, 67, 643-650.
11. P. Cohen, M. Miyazaki, N. D. Socci, A. Hagge-Greenberg, W. Liedtke, A. A. Soukas, R. Sharma, L. C. Hudgins, J. M. Ntambi, J. M. Friedman: Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss. Science. 2002, 297, 240-243.
12. M. Miyazaki, A. Dobrzyn, H. Sampath, S. H. Lee, W. C. Man, K. Chu, J. M. Peters, F. J. Gonzalez, J. M Ntambi: Reduced adiposity and liver steatosis by stearoyl-CoA desaturase deficiency are independent of peroxisome proliferator-activated receptor-alpha. J Biol Chem. 2004, 279, 35017-35024.
13. J. D. McGarry: Banting lecture 2001: Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002, 51, 7-18.
14. G. F. Lewis, A. Carpentier, K. Adeli, A. Giacca: Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002, 23, 201-229.
15. R. H. Unger: Lipotoxic diseases. Annu Rev Med. 2002, 53, 319-336.
16. G. I. Shulman: Cellular mechanisms of insulin resistance. J Clin Invest. 2000, 106, 171-176.
17. J. M. Ntambi, M. Miyazaki: Regulation of stearoyl-CoA desaturases and role in metabolism. Prog Lipid Res. 2004, 43, 91-104.
18. L. L. Listenberger, X. Han, S. E. Lewis, S. Cases, R. V. Farese, D. S. Ory, J. E. Schaffer: Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc Natl Acad Sci USA. 2003, 100, 3077-3082.
19. T. K. Lam, R. Gutierrez-Juarez, A. Pocai, S. Bhanot, P. Tso, G. J. Schwartz, L. Rossetti: Brain glucose metabolism controls the hepatic secretion of triglyceride-rich lipoproteins. Nat Med. 2007, 13, 171-180.
20. M. Miyazaki, Y. C. Kim, M. P. Gray-Keller, A. D. Attie, J. M. Ntambi: The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem. 2000, 275, 30132-30138.
21. A. Dobrzyn, P. Dobrzyn, M. Miyazaki, H. Sampath, K. Chu, J. M. Ntambi: Stearoyl-CoA desaturase 1 deficiency increases CTP:choline cytidylyltransferase translocation into the membrane and enhances phosphatidylcholine synthesis in liver. J Biol Chem. 2005, 280, 23356-23362.
22. K. Chu, M. Miyazaki, W. C. Man, J. M. Ntambi: Stearoylcoenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol Cell Biol. 2006, 26, 6786-6798.
23. H. Xu, D. Wilcox, P. Nguyen, M. Voorbach, H. Smith, S. Brodjian, T. Suhar, R. M. Reilly, P. B. Jacobson, C. A. Collins, K. Landschulz, T. K. Surowy: Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition. Front Biosci. 2007, 12, 3781-3794.
24. M. Miyazaki, A. Dobrzyn, W. C. Man, K. Chu, H. Sampath, H. J. Kim, J. M. Ntambi: Stearoyl-CoA desaturase 1 gene expression is necessary for fructose-mediated induction of lipogenic gene expression by sterol regulatory element-binding protein-1c-dependent and -independent mechanisms. J Biol Chem. 2004, 279, 25164-25171.
25. P. Dobrzyn, A. Dobrzyn, M. Miyazaki, P. Cohen, E. Asilmaz, D. G. Hardie, J. M. Friedman, J. M. Ntambi: Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc Natl Acad Sci USA. 2004, 101, 6409-6414.
26. S. B. Biddinger, M. Miyazaki, J. Boucher, J. M. Ntambi, C. R. Kahn: Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c. Diabetes. 2006, 55, 2032-2041.
27. H. K. Stals, G. P. Mannaerts, P. E. Declercq: Factors influencing triacylglycerol synthesis in permeabilized rat hepatocytes. Biochem J. 1992, 283, 719-725.
28. M. Miyazaki, Y. C. Kim, J. M. Ntambi: A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J Lipid Res. 2001, 42, 1018-1024.
29. Y. Zheng, K. J. Eilertsen, L. Ge, L. Zhang, J. P. Sundberg, S. M. Prouty, K. S. Stenn, S. Parimoo: SCD1 is expressed in sebaceous glands and is disrupted in the asebia mouse. Nat Genet. 1999, 23, 268-270.
30. J. M. Ntambi, M. Miyazaki, J. P. Stoehr, H. Lan, C. M. Kendziorski, B. S. Yandell, Y. Song, P. Cohen, J. M. Friedman, A. D. Attie: Loss of stearoyl-CoA desaturase-1 function protects mice against adiposity. Proc Natl Acad Sci USA. 2002, 99, 11482-11486.
31. A. Dobrzyn, P. Dobrzyn, S. H. Lee, M. Miyazaki, P. Cohen, E. Asilmaz, D. G. Hardie, J. M. Friedman, J. M. Ntambi: Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing beta-oxidation in skeletal muscle. Am J Physiol Endocrinol Metab. 2005, 288, E599-E607.
32. S. H. Lee, A. Dobrzyn, P. Dobrzyn, S. M. Rahman, M. Miyazaki, J. M. Ntambi: Lack of stearoyl-CoA desaturase 1 upregulates basal thermogenesis but causes hypothermia in a cold environment. J Lipid Res. 2004, 45, 1674-1682.
33. D. G. Hardie: The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Sci. 2004, 117, 5479-5487.
34. A. Dobrzyn, P. Dobrzyn, M. Miyazaki, J. M. Ntambi: Polyunsaturated fatty acids do not activate AMP-activated protein kinase in mouse tissues. Biochem Biophys Res Commun. 2005, 332, 892-896.
35. H. Sampath, M. Miyazaki, A. Dobrzyn, J. M. Ntambi: Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem. 2007, 282, 2483-2493.
36. S. Kersten, J. Seydoux, J. M. Peters, F. J. Gonzalez, B. Desvergne, W. Wahli: Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting. J Clin Invest. 1999, 103, 1489-1498.
37. P. Angulo: Nonalcoholic fatty liver disease. N Engl J Med. 2002, 346, 1221-1231.
38. S. Bellentani, G. Saccoccio, F. Masutti, L. S. Croce, G. Brandi, F. Sasso, G. Cristanini, C. Tiribelli: Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000, 132, 112-117.
39. G. Marchesini, M. Brizi, G. Bianchi, S. Tomassetti, E. Bugianesi, M. Lenzi, A. J. McCullough, S. Natale, G. Forlani, N. Melchionda: Nonalcoholic fatty liver disease: A feature of the metabolic syndrome. Diabetes. 2001, 50, 1844-1850.
40. B. Fromenty, M. A. Robin, A. Igoudjil, A. Mansouri, D. Pessayre: The ins and outs of mitochondrial dysfunction in NASH. Diabetes Metab. 2004, 30, 121-138.
41. D. Festi, A. Colecchia, T. Sacco, M. Bondi, E. Roda, G. Marchesini: Hepatic steatosis in obese patients: Clinical aspects and prognostic significance. Obes Rev. 2004, 5, 27-42.
42. M. Miyazaki, M. T. Flowers, H. Sampath, K. Chu, C. Otzelberger, X. Liu, J. M. Ntambi: Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis. Cell Metab. 2007, 6, 484-496.
43. J. Araya, R. Rodrigo, L. A. Videla, L. Thielemann, M. Orellana, P. Pettinelli, J. Poniachik: Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin Sci. 2004, 106, 635-643.
44. I. Shimomura, H. Shimano, B. S. Korn, Y. Bashmakov, J. D. Horton: Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver. J Biol Chem. 1998, 273, 35299-35306.
45. E. Asilmaz, P. Cohen, M. Miyazaki, P. Dobrzyn, K. Ueki, G. Fayzikhodjaeva, A. A. Soukas, C. R. Kahn, J. M. Ntambi, N. D. Socci, J. M. Friedman: Site and mechanism of leptin action in a rodent form of congenital lipodystrophy. J Clin Invest. 2004, 113, 414-424.
46. H. C. Chen, R. V. Farese: Turning WAT into BAT gets rid of fat. Nat Med. 2001, 7, 1102-1103.
47. J. B. Flowers, M. E. Rabaglia, K. L. Schueler, M. T. Flowers, H. Lan, M. P. Keller, J. M. Ntambi, A. D. Attie: Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice. Diabetes. 2007, 56, 1228-1239.
48. R. Gutierrez-Juarez, A. Pocai, C. Mulas, H. Ono, S. Bhanot, B. P. Monia, L. Rossetti: Critical role of stearoyl-CoA desaturase-1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J Clin Invest. 2006, 116, 1686-1695.
49. G. S. Olsen, B. F. Hansen: AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle. Am J Physiol Endocrinol Metab. 2002, 283, E965-E970.
50. M. A. Iglesias, J. M. Ye, G. Frangioudakis, A. K. Saha, E. Tomas, N. B. Ruderman, G. J. Cooney, E. W. Kraegen: AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes. 2002, 51, 2886-2894.
51. N. D. Oakes, K. S. Bell, S. M. Furler, S. Camilleri, A. K. Saha, N. B. Ruderman, D. J. Chisholm, E. W. Kraegen: Diet-induced muscle insulin resistance in rats is ameliorated by acute dietary lipid withdrawal or a single bout of exercise: Parallel relationship between insulin stimulation of glucose uptake and suppression of long-chain fatty acyl-CoA. Diabetes. 1997, 46, 2022-2028.
52. S. M. Rahman, A. Dobrzyn, S. H. Lee, P. Dobrzyn, M. Miyazaki, J. M. Ntambi: Stearoyl-CoA desaturase 1 deficiency increases insulin signaling and glycogen accumulation in brown adipose tissue. Am J Physiol Endocrinol Metab. 2005, 288, E381-E387.
53. M. Elchebly, P. Payette, E. Michaliszyn, W. Cromlish, S. Collins, A. L. Loy, D. Normandin, A. Cheng, J. Himms-Hagen, C. C. Chan, C. Ramachandran, M. J. Gresser, M. L. Tremblay, B. P. Kennedy: Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science. 1999, 283, 1544-1548.
54. M. Borkman, L. H. Storlien, D. A. Pan, A. B. Jenkins, D. J. Chisholm, L. V. Campbell: The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med. 1993, 328, 238-244.
55. V. K. Yechoor, M. E. Patti, K. Ueki, P. G. Laustsen, R. Saccone, R. Rauniyar, C. R. Kahn: Distinct pathways of insulin-regulated versus diabetes-regulated gene expression: An in vivo analysis in MIRKO mice. Proc Natl Acad Sci USA. 2004, 101, 16525-16530.
56. M. D. Voss, A. Beha, N. Tennagels, G. Tschank, A. W. Herling, M. Quint, M. Gerl, C. Metz-Weidmann, G. Haun, M. Korn: Gene expression profiling in skeletal muscle of Zucker diabetic fatty rats: Implications for a role of stearoyl-CoA desaturase 1 in insulin resistance. Diabetologia. 2005, 48, 2622-2630.
57. L. Zhang, L. Ge, S. Parimoo, K. Stenn, S. M. Prouty: Human stearoyl-CoA desaturase: Alternative transcripts generated from a single gene by usage of tandem polyadenylation sites. Biochem J. 1999, 340, 255-264.
58. S. Beiraghi, M. Zhou, C. B. Talmadge, N. Went-Sumegi, J. R. Davis, D. Huang, H. Saal, T. A. Seemayer, J. Sumegi: Identification and characterization of a novel gene disrupted by a pericentric inversion inv (4)(p13_1q21.1) in a family with cleft lip. Gene. 2003, 309, 11-21.
59. S. Zhang, Y. Yang, Y. Shi: Characterization of human SCD2, an oligomeric desaturase with improved stability and enzyme activity by cross-linking in intact cells. Biochem J. 2005, 15, 135-142.
60. E. Warensjö, E. Ingelsson, P. Lundmark, L. Lannfelt, A. C. Syvänen, B. Vessby, U. Risérus: Polymorphisms in the SCD1 gene: Associations with body fat distribution and insulin sensitivity. Obesity. 2007, 15, 1732-1740.
61. A. D. Attie, R. M. Krauss, M. P. Gray-Keller, A. Brownlie, M. Miyazaki, J. J. Kastelein, A. J. Lusis, A. F. Stalenhoef, J. P. Stoehr, M. R. Hayden, J. M. Ntambi: Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia. J Lipid Res. 2002, 43, 1899-1907.
62. Y. Sun, M. Hao, Y. Luo, C. P. Liang, D. L. Silver, C. Cheng, F. R. Maxfield, A. R. Tall: Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J Biol Chem. 2003, 278, 5813-5820.